Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view.

Liu, Yang; Khan, Suliman; Li, Lin; Ten Hagen, Timo L M; Falahati, Mojtaba

Liu, Yang; Khan, Suliman; Li, Lin; Ten Hagen, Timo L M; Falahati, Mojtaba.

Afiliação

Liu Y; Department of Thyroid Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China. Electronic address: doctorliuyang@126.com.
Khan S; Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, China; Department of Medical Lab Technology, The University of Haripur, 22650, Pakistan. Electronic address: suliman.khan18@mails.ucas.ac.cn.
Li L; Department of Dermatology, The Affiliated Children's Hospital of Zhengzhou University, Zhengzhou 450000, China.
Ten Hagen TLM; Laboratory Experimental Oncology, Department of Pathology, Erasmus MC, 3015GD Rotterdam, the Netherlands.
Falahati M; Laboratory Experimental Oncology, Department of Pathology, Erasmus MC, 3015GD Rotterdam, the Netherlands.

Biomed Pharmacother ; 146: 112251, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34916087

Assuntos

RNA; Neoplasias da Glândula Tireoide/genética; Animais; Resistencia a Medicamentos Antineoplásicos/genética; Transição Epitelial-Mesenquimal; Humanos; Transdução de Sinais

Palavras-chave

CeRNA; Long non-coding RNA; MicroRNA, circular RNA; Thyroid cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: RNA / Neoplasias da Glândula Tireoide Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google